Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.
Leukocyte Migration-Inhibitory Factors
Hypesthesia
Positron Emission Tomography Computed Tomography
Objective changes in motor function during placebo treatment in PD.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Objective changes in motor function during placebo treatment in PD.
Objective changes in motor function during placebo treatment in PD. Neurology. 2000 Feb 08; 54(3):710-4.
View in:
PubMed
subject areas
Aged
Female
Humans
Male
Middle Aged
Movement
Parkinson Disease
Placebos
authors with profiles
Sue Leurgans